Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma
2018 ◽
Vol 32
(5)
◽
pp. 1147-1156
◽
M. -L. Nairismägi
◽
M. E. Gerritsen
◽
Z. M. Li
◽
G. C. Wijaya
◽
B. K. H. Chia
◽
...
Yu Feng
◽
Caixia Jing
◽
Xinmei Yu
◽
Xia Cao
◽
Caigang Xu
1998 ◽
Vol 134
(1)
◽
pp. 109-111
◽
Elzbieta Mechel
◽
Ann. Q. Tran
◽
Victoria S. North
◽
Farnoush M. Moen
◽
Andrea A. Tooley
2021 ◽
Vol 98
◽
pp. 107829
Meiyu Chen
◽
Yu Jiang
◽
Xiaohui Cai
◽
Xuzhang Lu
◽
Hongying Chao
2018 ◽
Vol Volume 14
◽
pp. 1083-1090
Qin Tong
◽
Shuming Ouyang
◽
Lingling Feng
◽
Hanyu Wang
◽
Yunfei Xia
◽
...
2012 ◽
Vol 24
(5)
◽
pp. 480-486
◽
2017 ◽
Vol 7
(1)
◽
pp. bio027557
◽
Yanwei Guo
◽
Hongqiao Zhang
◽
Xin Xing
◽
Lijuan Wang
◽
Jian Zhang
◽
...
2016 ◽
Vol 17
(3)
◽
pp. 271-273
◽
Close
Export Citation Format
Close
Share Document
Close